RNAZ
USDTransCode Therapeutics Inc. Common Stock
$9.500-0.410 (-4.137%)
Prix en Temps Réel
Healthcare
Biotechnologie
États-Unis
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$9.910
Haut
$10.450
Bas
$9.500
Volume
0.01M
Fondamentaux de l'Entreprise
Capitalisation Boursière
8.7M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.14M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Bas $6.15Actuel $9.500Haut $494.34
Actualités Connexes
PR Newswire
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
Voir plus
PR Newswire
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.